🧬
Biyoteknoloji Sektörü Hisseleri
Biyoteknoloji Sektörü altında 522 Hisse Senedi
Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
Biyoteknoloji Sektörü Hakkında
Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.
Temel Özellikler
- Yüksek AR-GE yatırımları
- Uzun geliştirme süreçleri
- Düzenleyici onay riskleri
- Yüksek büyüme potansiyeli
Önemli Şirketler
ModernaGilead SciencesBiogenRegeneron
522
Toplam Hisse
$2.5T
Toplam Piyasa Değeri
Biyoteknoloji Sektörü Hisseleri
Sayfa 4/6 (Toplam: 522)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| CHRS | Coherus BioSciences, Inc. | $97.36M | $0.78 | 2.87% | |
| MGNX | MacroGenics, Inc. | $97.16M | $1.36 | 2.86% | |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $97.02M | $3.66 | 2.52% | |
| OPTN | OptiNose, Inc. | $95.91M | $9.60 | 0.00% | |
| HLVX | HilleVax, Inc. | $95.77M | $1.87 | 0.54% | |
| SGMT | Sagimet Biosciences Inc. | $95.09M | $3.55 | 1.43% | |
| AADI | Aadi Bioscience, Inc. | $94.89M | $2.05 | 2.38% | |
| IMUX | Immunic, Inc. | $93.97M | $0.66 | 2.97% | |
| GNLX | Genelux Corporation | $92.64M | $2.42 | 1.63% | |
| AGEN | Agenus Inc. | $91.84M | $3.43 | 7.19% | |
| ORMP | Oramed Pharmaceuticals Inc. | $91.51M | $2.34 | 4.93% | |
| KYTX | Kyverna Therapeutics, Inc. | $90.54M | $2.55 | 3.04% | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $89.71M | $7.42 | 2.62% | |
| SAVA | Cassava Sciences, Inc. | $89.37M | $2.01 | 1.47% | |
| TIL | Instil Bio, Inc. | $87.76M | $26.95 | 11.20% | |
| ANIX | Anixa Biosciences, Inc. | $85.97M | $2.57 | 1.53% | |
| GUTS | Fractyl Health, Inc. Common Stock | $85.71M | $1.90 | 0.00% | |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $85.48M | $2.72 | 5.23% | |
| SNTI | Senti Biosciences, Inc. | $83.20M | $3.14 | 0.96% | |
| PLRX | Pliant Therapeutics, Inc. | $83.18M | $1.35 | 1.46% | |
| GALT | Galectin Therapeutics Inc. | $83.08M | $1.31 | 5.65% | |
| SERA | Sera Prognostics, Inc. | $82.40M | $1.56 | 4.88% | |
| INZY | Inozyme Pharma, Inc. | $79.09M | $3.97 | 0.51% | |
| TELO | Telomir Pharmaceuticals, Inc. Common Stock | $78.57M | $1.95 | 7.38% | |
| OCX | OncoCyte Corporation | $75.18M | $3.32 | 1.84% | |
| CRVO | CervoMed Inc. | $74.58M | $7.22 | 7.32% | |
| CNTX | Context Therapeutics Inc. | $73.99M | $0.58 | 6.50% | |
| JSPR | Jasper Therapeutics, Inc. | $73.76M | $5.50 | 3.17% | |
| RFL | Rafael Holdings, Inc. | $73.65M | $1.43 | 2.14% | |
| TCRX | TScan Therapeutics, Inc. | $71.59M | $1.43 | 2.72% | |
| CLSD | Clearside Biomedical, Inc. | $69.54M | $0.76 | 2.44% | |
| BYSI | BeyondSpring Inc. | $69.35M | $1.75 | 0.19% | |
| NOTV | Inotiv, Inc. | $68.53M | $2.60 | 7.14% | |
| INO | Inovio Pharmaceuticals, Inc. | $68.03M | $2.00 | 6.10% | |
| IGMS | IGM Biosciences, Inc. | $67.55M | $1.27 | 4.51% | |
| PYXS | Pyxis Oncology, Inc. | $67.21M | $1.21 | 3.20% | |
| CABA | Cabaletta Bio, Inc. | $66.98M | $1.87 | 2.09% | |
| NVNO | enVVeno Medical Corporation | $66.81M | $3.61 | 3.73% | |
| MNOV | MediciNova, Inc. | $66.70M | $1.39 | 2.11% | |
| ANRO | Alto Neuroscience, Inc. | $64.16M | $2.58 | 4.09% | |
| MCRB | Seres Therapeutics, Inc. | $63.83M | $7.05 | 0.56% | |
| ABOS | Acumen Pharmaceuticals, Inc. | $63.60M | $1.02 | 2.86% | |
| STRO | Sutro Biopharma, Inc. | $62.38M | $0.90 | 0.26% | |
| APLT | Applied Therapeutics, Inc. | $62.31M | $0.35 | 2.00% | |
| OTLK | Outlook Therapeutics, Inc. | $62.14M | $1.84 | 2.22% | |
| TNYA | Tenaya Therapeutics, Inc. | $61.85M | $0.46 | 3.51% | |
| BSGM | BioSig Technologies, Inc. | $61.12M | $5.60 | 10.89% | |
| RPHM | Reneo Pharmaceuticals, Inc. | $60.84M | $18.20 | 952.02% | |
| PDSB | PDS Biotechnology Corporation | $60.52M | $1.38 | 1.43% | |
| SKYE | Skye Bioscience, Inc. | $60.26M | $1.98 | 6.60% | |
| CUE | Cue Biopharma, Inc. | $57.49M | $0.64 | 0.93% | |
| IMMX | Immix Biopharma, Inc. | $56.03M | $2.34 | 4.00% | |
| MGX | Metagenomi, Inc. Common Stock | $55.89M | $1.70 | 4.49% | |
| ACET | Adicet Bio, Inc. | $55.25M | $0.72 | 0.24% | |
| RENB | Renovaro Biosciences Inc. | $55.23M | $0.31 | 1.68% | |
| SER | Serina Therapeutics, Inc. | $54.82M | $6.00 | 4.35% | |
| MAIA | MAIA Biotechnology, Inc. | $54.70M | $1.79 | 1.10% | |
| CTSO | Cytosorbents Corporation | $54.47M | $0.84 | 2.44% | |
| DTIL | Precision BioSciences, Inc. | $54.33M | $4.83 | 1.83% | |
| BDSX | Biodesix, Inc. | $52.59M | $0.30 | 7.22% | |
| PRLD | Prelude Therapeutics Incorporated | $51.59M | $0.89 | 1.77% | |
| ARMP | Armata Pharmaceuticals, Inc. | $51.39M | $1.95 | 10.14% | |
| OMIC | Singular Genomics Systems, Inc. | $50.77M | $20.01 | 0.00% | |
| AKYA | Akoya Biosciences, Inc. | $50.62M | $1.25 | 0.81% | |
| FBIO | Fortress Biotech, Inc. | $50.56M | $1.89 | 3.08% | |
| ARTV | Artiva Biotherapeutics, Inc. | $49.94M | $1.93 | 5.85% | |
| RNTX | Rein Therapeutics Inc. | $49.48M | $1.95 | 0.52% | |
| ALVR | AlloVir, Inc. | $49.48M | $9.81 | 4.14% | |
| OPGN | OpGen, Inc. | $48.83M | $4.70 | 2.29% | |
| ATNM | Actinium Pharmaceuticals, Inc. | $47.42M | $1.54 | 2.53% | |
| IKNA | Ikena Oncology, Inc. | $46.92M | $1.19 | 0.85% | |
| ADVM | Adverum Biotechnologies, Inc. | $46.27M | $2.22 | 1.77% | |
| ALRN | Aileron Therapeutics, Inc. | $45.72M | $2.11 | 9.33% | |
| LTRN | Lantern Pharma Inc. | $45.45M | $3.05 | 2.56% | |
| MRSN | Mersana Therapeutics, Inc. | $45.44M | $0.34 | 1.52% | |
| PEPG | PepGen Inc. | $44.99M | $1.46 | 12.57% | |
| IMRX | Immuneering Corporation | $44.98M | $1.71 | 0.89% | |
| CELU | Celularity Inc. | $44.79M | $2.11 | 7.46% | |
| KRON | Kronos Bio, Inc. | $44.63M | $0.68 | 0.52% | |
| PMVP | PMV Pharmaceuticals, Inc. | $44.49M | $0.88 | 1.92% | |
| HOWL | Werewolf Therapeutics, Inc. | $44.21M | $1.21 | 5.47% | |
| STTK | Shattuck Labs, Inc. | $43.48M | $1.01 | 6.48% | |
| OSTX | OS Therapies Incorporated | $43.37M | $1.53 | 3.16% | |
| KPTI | Karyopharm Therapeutics Inc. | $41.90M | $4.20 | 7.28% | |
| CCEL | Cryo-Cell International, Inc. | $40.80M | $5.12 | 0.39% | |
| CAMP | CAMP4 Therapeutics Corporation | $40.73M | $1.98 | 4.81% | |
| ATRA | Atara Biotherapeutics, Inc. | $39.82M | $7.80 | 0.00% | |
| TELA | TELA Bio, Inc. | $39.75M | $1.39 | 2.21% | |
| QNCX | Quince Therapeutics, Inc. | $38.17M | $1.04 | 0.00% | |
| NRXP | NRx Pharmaceuticals, Inc. | $37.98M | $2.64 | 1.86% | |
| SCYX | SCYNEXIS, Inc. | $37.73M | $0.88 | 2.15% | |
| LUMO | Lumos Pharma, Inc. | $37.54M | $4.34 | 0.00% | |
| GRCE | Grace Therapeutics, Inc. | $37.07M | $2.77 | 3.38% | |
| SPRO | Spero Therapeutics, Inc. | $36.34M | $2.50 | 17.37% | |
| ECOR | electroCore, Inc. | $36.21M | $5.00 | 2.04% | |
| ANTX | AN2 Therapeutics, Inc. | $35.52M | $1.06 | 12.40% | |
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $35.43M | $1.05 | 4.55% | |
| RMTI | Rockwell Medical, Inc. | $34.69M | $0.98 | 4.13% | |
| BOLD | Boundless Bio, Inc. | $34.57M | $1.10 | 5.98% | |
| LIAN | LianBio | $34.47M | $0.32 | 0.00% |